Juming Lu
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes Management and Education
- Nephrology top 5%
Papers in ⓘ
-
- Diabetes Treatment and Management 30
- Diabetes, Cardiovascular Risks, and Lipoproteins 28
- Diabetes Management and Research 26
- Pituitary Gland Disorders and Treatments 11
- Adrenal Hormones and Disorders 8
- Hormonal Regulation and Hypertension 8
- Co-authors
- Jianping Weng (19 shared papers)Weiping Jia (16 shared papers)Haoming Tian (12 shared papers)Zhiguang Zhou (15 shared papers)Wenying Yang (14 shared papers)Linong Ji (18 shared papers)Lixiang Lin (5 shared papers)Qiuhe Ji (12 shared papers)
- Journals
- Diabetes Research and Clinical Practice (5 papers)Journal of Diabetes (4 papers)PLoS ONE (4 papers)Diabetes/Metabolism Research and Reviews (3 papers)Advances in Therapy (3 papers)
- Partner nations
- ChinaUnited StatesPhilippines
In The Last Decade
Juming Lu
93 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 135
- Endocrinology, Diabetes and Metabolism 2.1k
- Nephrology 200
- Cardiology and Cardiovascular Medicine 629
- Epidemiology 774
- Physiology 492
Countries citing papers authored by Juming Lu
This map shows the geographic impact of Juming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juming Lu more than expected).
Fields of papers citing papers by Juming Lu
This network shows the impact of papers produced by Juming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juming Lu. The network helps show where Juming Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Juming Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 94 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prevalence of Diabetes among Men and Women in China Hit paper breakdown → | 2010 | 2488 |
| 2 | 2013 | 211 | |
| 3 | 2013 | 131 | |
| 4 | 2013 | 128 | |
| 5 | 2003 | 114 | |
| 6 | 2014 | 69 | |
| 7 | 2013 | 60 | |
| 8 | 2012 | 53 | |
| 9 | 2012 | 45 | |
| 10 | 2017 | 45 | |
| 11 | 2017 | 44 | |
| 12 | 2010 | 41 | |
| 13 | 2014 | 41 | |
| 14 | 2018 | 38 | |
| 15 | 2008 | 34 | |
| 16 | 2014 | 34 | |
| 17 | 2015 | 33 | |
| 18 | 2018 | 32 | |
| 19 | 2017 | 31 | |
| 20 | 2013 | 31 |
About Juming Lu
Juming Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research, Surgery, Nephrology and Genetics, having authored 94 papers that have together received 4.3k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (30 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (28 papers), Diabetes Management and Research (26 papers), Metabolism, Diabetes, and Cancer (13 papers), Pituitary Gland Disorders and Treatments (11 papers), Adrenal Hormones and Disorders (8 papers), Hormonal Regulation and Hypertension (8 papers) and Adrenal and Paraganglionic Tumors (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (2.1k citations), Nephrology (200 citations), Cardiology and Cardiovascular Medicine (629 citations), Epidemiology (774 citations) and Physiology (492 citations). Juming Lu has collaborated with scholars based in China, United States and Philippines. Frequent co-authors include Jianping Weng, Weiping Jia, Haoming Tian, Zhiguang Zhou, Wenying Yang, Linong Ji, Lixiang Lin, Qiuhe Ji, Zhongyan Shan and Jianzhong Xiao. Their work appears in journals such as Diabetes Research and Clinical Practice, Journal of Diabetes, PLoS ONE, Diabetes/Metabolism Research and Reviews and Advances in Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.